Sun Pharma launches generic version of Pfizer's blockbuster cancer drug
The price of the palbociclib treatment, which used to be at least ₹50,000 a month, will come down substantially.
The price of the palbociclib treatment, which used to be at least ₹50,000 a month, will come down substantially.
India needs a new regime to stem the outflow of $8.6 billion a year for using intellectual property of foreign entities. Here's the road ahead.